我院由1958年12月份单独试用链霉素0.2克注射“肺俞”“膏盲”穴位,治疗活动性肺结核20例,兹初步报道如下: 一、疗效考核标准 1.显著进步:病灶吸收2/3以上或空洞闭合者;2.中度进步:病灶吸收1/3—2/3或空洞缩小1/2以上者;3.轻度进步:病灶略有吸收,或空洞稍有缩小者;4.无变化:治疗前后无何改变者;5.恶化:病灶增多,扩大或溶解者。 In our hospital from December 1958 separate trial streptomycin 0.2 g injection “Feishu” “cream blind” points, the treatment of 20 cases of active tuberculosis, it is initially reported as follows: First, the efficacy evaluation criteria 1. Significant improvement: the absorption of lesions 2 / 3 or more closed or empty; 2 moderate progress: lesion absorption 1 / 3-2 / 3 or cavity shrink more than 1/2; 3 mild progress: lesions slightly absorbed, or slightly reduced cavity; 4. No change: no change before and after treatment; 5. Deterioration: increased lesions, expansion or dissolution.